Assessing the risk of bleeding and clotting in cirrhosis
- PMID: 31041022
- PMCID: PMC6490249
- DOI: 10.1002/cld.528
Assessing the risk of bleeding and clotting in cirrhosis
References
-
- Shah NL, Northup PG, Caldwell SH. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol 2012;11:686‐690. - PubMed
-
- Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147‐156. - PubMed
-
- Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant 2007;7:1624‐1628. - PubMed
-
- Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 2003;98:1391‐1394. - PubMed
-
- Tripodi A, Primignani M, Chantarangkul V, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006;44:440‐445. - PubMed
Publication types
LinkOut - more resources
Full Text Sources